Barbara is a veteran entrepreneur and molecular medical geneticist who has pioneered the responsible application of genetics to clinical medicine over a 25 year career.
In 1987 Barbara established one of the first commercial DNA testing laboratories at Integrated Genetics (now Genzyme Genetics). After co-founding a gene therapy company in 1995 (Genovo), Barbara began her own consulting practice, Handelin Associates. She delivered consulting services to venture capital investors, start ups, biomedical universities, as well as established biotechnology, diagnostics, genomics, pharmacogenomics and bioinformatics companies. She founded a biosimulation company, Kenna Technologies (2000), serving as CEO until its acquisition by DNA Print Genomics and thereafter as Director of Diagnostics and Computational Modeling, where she led the development of new pharmacogenetics diagnostic tests.
Barbara served 3 years on the board of RedPath Integrated Pathology, Inc. and on advisory boards of several other genomics companies (eg. EXACT Sciences). She served 10 years as a board member of Public Responsibility in Medicine and Research (PRIM&R) as well as on a variety of federal committees and advisory panels on ethics in genetic testing, including the Secretary? s Advisory Panel on Genetics, Health and Society. She received her BA, Genetics at University of California, Berkeley and her Ph.D., Medical Genetics at OHSU with her thesis completed at MIT with Dr. David Housman.